FDA.reportPublic FDA data

ciprofloxacin

Product NDC
50090-1649
11-digit product format
500901649
Labeler code
50090
Product ID
50090-1649_9244d2d7-3da2-46a0-a870-9d1196df1504
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ciprofloxacin
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA076639
Marketing category
ANDA
Marketing start
2004-09-10
Substance
CIPROFLOXACIN HYDROCHLORIDE
Active strength
500 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
ciprofloxacin
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CIPROFLOXACIN HYDROCHLORIDE500 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii4BA73M5E37
Rxcui309309

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ea50b939-d92a-4100-84f5-1c1089663837Product name220240705
90aab9f8-63f3-478d-8db8-951525a18ab1Product name120180814
200e1d3d-46da-4371-beed-747da3cb3ff8Product name120180702
9e453f34-aacb-44d5-a119-c0e3dc1fca2aProduct name120160622
01eecbfe-0b50-413b-8898-6905c89b6568Product name120151228
a3304bb6-ef4e-06df-d604-35f7e883ed6cProduct name120140508
abaf203f-619e-f265-559f-8c81af5cb1c2Product name120140508
de5ea793-ffd9-0308-b0ca-00d9967be4eeProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50090-1649-02023-10-24C16284748780-1f386c649-d3cf-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987
50090-1649-02023-01-30C16284748780-1f386c649-d3cf-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-1649-0ciprofloxacin20 in 1 BOTTLETABLET2013
50090-1649-1ciprofloxacin14 in 1 BOTTLETABLET1413

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-1649CIPROFLOXACIN TABLET [A-S MEDICATION SOLUTIONS]13Current NDC, Legacy NDC, 2 package rows20231115_6971a958-08f0-4712-bf5f-47fe4f76b863.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
309309ciprofloxacin 500 MG Oral TabletPSN6971a958-08f0-4712-bf5f-47fe4f76b86313
309309ciprofloxacin 500 MG Oral TabletSCD6971a958-08f0-4712-bf5f-47fe4f76b86313
309309ciprofloxacin (as ciprofloxacin HCl) 500 MG Oral TabletSY6971a958-08f0-4712-bf5f-47fe4f76b86313

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-1649-05009016490020 TABLET in 1 BOTTLE (50090-1649-0) 20 tablet2015-01-190000-00-00NoNoCurrent
50090-1649-15009016490114 TABLET in 1 BOTTLE (50090-1649-1) 14 tablet2023-10-31NoNoCurrent